Nkarta Stock (NASDAQ:NKTX), Quotes and News Summary

Q: What sector and industry does Nkarta (NKTX) operate in?

Nkarta is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Nkarta Stock (NASDAQ: NKTX) stock price, news, charts, stock research, profile.

Open	$6.690
Close	$6.550
Volume / Avg.	1.632M / 1.013M
Day Range	6.310 - 6.785
52 Wk Range	1.280 - 16.240
Market Cap	$461.563M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	10.49%
Days to Cover	5.18

Recent News

Small-Cap Firm Century Therapeutics' Expands into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing

Century Therapeutics unveils plans to expand CNTY-101 clinical development into additional autoimmune diseases, including systemic lupus erythematosus. $60 million private placement supports R&D activities. Acquisition of Clade Therapeutics enhances pipeline with iPSC-focused programs.

Vandana Singh

Nasdaq Turns Higher; Akanda Shares Plunge

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Monday. The Dow traded down 0.37% to 39,331.42 while the NASDAQ rose 0.06% to 16,439.38. The S&P 500 also fell, dropping, 0.12% to 5,227.95.

Avi Kapoor

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Jan

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Nkarta (NKTX) stock?

You can purchase shares of Nkarta (NASDAQ: NKTX) through any online brokerage.

View our list of the best stock brokerages.

Who are Nkarta's (NKTX) competitors?

Other companies in Nkarta’s space includes: KalVista Pharma (NASDAQ:KALV), Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO), Larimar Therapeutics (NASDAQ:LRMR) and PepGen (NASDAQ:PEPG).

What is the target price for Nkarta (NKTX) stock?

The latest price target for Nkarta (NASDAQ: NKTX) was reported by HC Wainwright & Co. on Monday, May 13, 2024. The analyst firm set a price target for 23.00 expecting NKTX to rise to within 12 months (a possible 251.15% upside). 24 analyst firms have reported ratings in the last year.

Current Stock Price for Nkarta (NKTX)?

The stock price for Nkarta (NASDAQ: NKTX) is $6.55 last updated Today at May 14, 2024 at 4:00 PM EDT.

Does Nkarta (NKTX) pay a dividend?

There are no upcoming dividends for Nkarta.

When is Nkarta (NASDAQ:NKTX) reporting earnings?

Nkarta’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Is Nkarta (NKTX) going to split?

There is no upcoming split for Nkarta.

What sector and industry does Nkarta (NKTX) operate in?

Nkarta is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-